Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index; none of the 68 sources its claims cite is checked for support yet.

Reversal of Phospholamban Inhibition of the Sarco(endo)plasmic Reticulum Ca2+-ATPase (SERCA) Using Short, Protein-interacting RNAs and Oligonucleotide Analogs

Open access
Soller, Kailey J., Yang, Jing, Veglia, Gianluigi, Bowser, Michael T. · 2016 · Journal of Biological Chemistry

Abstract

The sarco(endo)plasmic reticulum Ca 2+ -ATPase (SERCA) and phospholamban (PLN) complex regulates heart relaxation through its removal of cytosolic Ca 2+ during diastole. Dysfunction of this complex has been related to many heart disorders and is therefore a key pharmacological target. There are currently no therapeutics that directly target either SERCA or PLN. It has been previously reported that single-stranded DNA binds PLN with strong affinity and relieves inhibition of SERCA in a length-dependent manner. In the current article, we demonstrate that RNAs and single-stranded oligonucleotide analogs, or xeno nucleic acids (XNAs), also bind PLN strongly ( K d <10 nm) and relieve inhibition of SERCA. Affinity for PLN is sequence-independent. Relief of PLN inhibition is length-dependent, allowing SERCA activity to be restored incrementally. The improved in vivo stability of XNAs offers more realistic pharmacological potential than DNA or RNA. We also found that microRNAs (miRNAs) 1 and 21 bind PLN strongly and relieve PLN inhibition of SERCA to a greater extent than a similar length random sequence RNA mixture. This may suggest that miR-1 and miR-21 have evolved to contain distinct sequence elements that are more effective at relieving PLN inhibition than random sequences.

Overview

CoChat Summary

TL;DR

Random-sequence RNAs and nuclease-resistant oligonucleotide analogs bind phospholamban (PLN) with low-nanomolar affinity and relieve PLN inhibition of SERCA in a length-dependent manner. miR-1 and miR-21 also bind PLN and fully restore SERCA basal activity, more effectively than a random 20-mer RNA mixture.

Key findings

  • Random-sequence RNA oligonucleotides longer than 5 nt bound PLN with high affinity; the 20-mer library showed 9–19 nM binding affinity. RNA showed no measurable affinity for SERCA (Kd > 4 µM) and only weak affinity for actin, myosin, and troponin.
  • RNA relieved PLN-mediated SERCA inhibition length-dependently; the 50-mer restored SERCA basal activity (no statistical difference from SERCA alone, p > 0.05), while all lengths other than 5-mer and 10-mer were statistically different from WT PLN (p < 0.05).
  • Charged XNAs (PT DNA, L-DNA, 2′-O-methyl RNA) bound PLN with Kd < 4 nM, similar to ssDNA/RNA; neutral PNA and morpholinos showed no measurable affinity. PT DNA had higher potency than the corresponding ssDNA 20-mer (p < 0.05), whereas L-DNA and 2′-O-methyl RNA gave less relief; only ssDNA and PT DNA showed pKCa statistically different from WT PLN.
  • miR-1 and miR-21 bound PLN tightly (Kd ∼40–60 nM, versus ∼10 nM for random sequence) and fully restored SERCA basal activity (pKCa not statistically different from SERCA alone), more efficiently than a similar-length random RNA mixture.

Methods

  • Binding affinities were measured by affinity capillary electrophoresis (ACE) and fluorescence polarization (FP) using FAM-labeled random-sequence oligonucleotide libraries titrated with PLN; a competition assay used unlabeled 20-mer RNA.
  • SERCA ATPase activity was measured with a coupled enzyme assay in DOPC:DOPE (4:1) lipid vesicles containing SERCA alone or SERCA plus recombinant PLN; XNAs were added and incubated 25 min before assay, and pKCa was estimated from Hill equation fits (n = 3 or n = 6 replicates).
  • SERCA1a was purified from rabbit skeletal muscle; PLN was recombinant; oligonucleotides included random-sequence ssDNA, RNA, 2′-O-methyl RNA, PT DNA, L-DNA, PNA, morpholinos, and miR-1/miR-21.

Limitations

  • Stated: only 20-mer XNAs were used because of limitations in oligonucleotide synthesis; since longer RNA lengths had more potent effects, longer XNA sequences were expected to have a greater impact on pKCa.
  • Stated: XNAs are potential therapeutics only if a suitable carrier can be developed; ssDNA is not viable due to short in vivo lifetime, and off-target/pleiotropic effects of miRNAs and antisense oligonucleotides may prevent therapeutic progression.
  • Evident from the text: the current study reports in vitro binding and reconstituted lipid-vesicle ATPase assays; no in vivo or cellular validation of XNA or miRNA effects on the SERCA-PLN complex is presented here.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1074/jbc.m116.738807

Cites

55 of 55 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

0 Valid · 0 Not valid · 30 Not checked · 52 Own results and interpretations

39 more claims

Create a free account to see all 82 claims and to verify the 68 references still open.

See all claims — free account
  • It may state two separate claims as one. 20
  • Probably not a substantial claim. 22

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 55 references

Cited by

Metadata

Authors
Soller, K. J., Yang, J., Veglia, G., & Bowser, M. T.
Affiliations
University of Minnesota (US)
Corresponding author
  • Veglia, Gianluigi
  • Bowser, Michael T.
Venue
Journal of Biological Chemistry
Publisher
Elsevier BV
Published
2016-10
Volume
291
Issue
41
Pages
21510-21518
ISSN
0021-9258 (ISSN-L)
OpenAlex
W2518314263
Cited by
20
References
55
Citations by year
2025: 2 · 2024: 1 · 2022: 2 · 2021: 2 · 2020: 2 · 2019: 4 · 2018: 5 · 2017: 1 · 2016: 1
FWCI
2.35
Type
journal article
Language
en
Open access
Licence
Locations
  • Journal of Biological Chemistry (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • PubMed Central (publishedVersion)
Funders
  • National Institutes of Health (GM063533, GM072701)
  • American Heart Association (13PRE16950023)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA and Nucleic Acid Chemistry
Keywords
phospholamban, SERCA, sarco/endoplasmic reticulum Ca2+-ATPase, RNA-protein interactions, XNA, oligonucleotide analogues, miR-1, miR-21, heart failure
MeSH terms
Phospholamban, Calcium-Binding Proteins, Humans, Oligonucleotides, MicroRNAs, Sarcoplasmic Reticulum Calcium-Transporting ATPases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-11-18, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-11-18 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.